Cargando…

Selective participation of c-Jun with Fra-2/c-Fos promotes aggressive tumor phenotypes and poor prognosis in tongue cancer

Tongue squamous cell carcinoma (TSCC) is most aggressive head and neck cancer often associated with HR-HPV infection. The role of AP-1 which is an essential regulator of HPV oncogene expression and tumorigenesis is not reported in tongue cancer. One hundred tongue tissue biopsies comprising precance...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Shilpi, Kumar, Prabhat, Kaur, Harsimrut, Sharma, Nishi, Saluja, Daman, Bharti, Alok C., Das, Bhudev C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652185/
https://www.ncbi.nlm.nih.gov/pubmed/26581505
http://dx.doi.org/10.1038/srep16811
_version_ 1782401704102199296
author Gupta, Shilpi
Kumar, Prabhat
Kaur, Harsimrut
Sharma, Nishi
Saluja, Daman
Bharti, Alok C.
Das, Bhudev C.
author_facet Gupta, Shilpi
Kumar, Prabhat
Kaur, Harsimrut
Sharma, Nishi
Saluja, Daman
Bharti, Alok C.
Das, Bhudev C.
author_sort Gupta, Shilpi
collection PubMed
description Tongue squamous cell carcinoma (TSCC) is most aggressive head and neck cancer often associated with HR-HPV infection. The role of AP-1 which is an essential regulator of HPV oncogene expression and tumorigenesis is not reported in tongue cancer. One hundred tongue tissue biopsies comprising precancer, cancer and adjacent controls including two tongue cancer cell lines were employed to study the role of HPV infection and AP-1 family proteins. An exclusive prevalence (28%) of HR-HPV type 16 was observed mainly in well differentiated tongue carcinomas (78.5%). A higher expression and DNA binding activity of AP-1 was observed in tongue tumors and cancer cell lines with c-Fos and Fra-2 as the major binding partners forming the functional AP-1 complex but c-Jun participated only in HPV negative and poorly differentiated carcinoma. Knocking down of Fra-2 responsible for aggressive tongue tumorigenesis led to significant reduction in c-Fos, c-Jun, MMP-9 and HPVE6/E7 expression but Fra-1 and p53 were upregulated. The binding and expression of c-Fos/Fra-2 increased as a function of severity of tongue lesions, yet selective participation of c-Jun appears to promote poor differentiation and aggressive tumorigenesis only in HPV negative cases while HPV infection leads to well differentiation and better prognosis preferably in nonsmokers.
format Online
Article
Text
id pubmed-4652185
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-46521852015-11-24 Selective participation of c-Jun with Fra-2/c-Fos promotes aggressive tumor phenotypes and poor prognosis in tongue cancer Gupta, Shilpi Kumar, Prabhat Kaur, Harsimrut Sharma, Nishi Saluja, Daman Bharti, Alok C. Das, Bhudev C. Sci Rep Article Tongue squamous cell carcinoma (TSCC) is most aggressive head and neck cancer often associated with HR-HPV infection. The role of AP-1 which is an essential regulator of HPV oncogene expression and tumorigenesis is not reported in tongue cancer. One hundred tongue tissue biopsies comprising precancer, cancer and adjacent controls including two tongue cancer cell lines were employed to study the role of HPV infection and AP-1 family proteins. An exclusive prevalence (28%) of HR-HPV type 16 was observed mainly in well differentiated tongue carcinomas (78.5%). A higher expression and DNA binding activity of AP-1 was observed in tongue tumors and cancer cell lines with c-Fos and Fra-2 as the major binding partners forming the functional AP-1 complex but c-Jun participated only in HPV negative and poorly differentiated carcinoma. Knocking down of Fra-2 responsible for aggressive tongue tumorigenesis led to significant reduction in c-Fos, c-Jun, MMP-9 and HPVE6/E7 expression but Fra-1 and p53 were upregulated. The binding and expression of c-Fos/Fra-2 increased as a function of severity of tongue lesions, yet selective participation of c-Jun appears to promote poor differentiation and aggressive tumorigenesis only in HPV negative cases while HPV infection leads to well differentiation and better prognosis preferably in nonsmokers. Nature Publishing Group 2015-11-19 /pmc/articles/PMC4652185/ /pubmed/26581505 http://dx.doi.org/10.1038/srep16811 Text en Copyright © 2015, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Gupta, Shilpi
Kumar, Prabhat
Kaur, Harsimrut
Sharma, Nishi
Saluja, Daman
Bharti, Alok C.
Das, Bhudev C.
Selective participation of c-Jun with Fra-2/c-Fos promotes aggressive tumor phenotypes and poor prognosis in tongue cancer
title Selective participation of c-Jun with Fra-2/c-Fos promotes aggressive tumor phenotypes and poor prognosis in tongue cancer
title_full Selective participation of c-Jun with Fra-2/c-Fos promotes aggressive tumor phenotypes and poor prognosis in tongue cancer
title_fullStr Selective participation of c-Jun with Fra-2/c-Fos promotes aggressive tumor phenotypes and poor prognosis in tongue cancer
title_full_unstemmed Selective participation of c-Jun with Fra-2/c-Fos promotes aggressive tumor phenotypes and poor prognosis in tongue cancer
title_short Selective participation of c-Jun with Fra-2/c-Fos promotes aggressive tumor phenotypes and poor prognosis in tongue cancer
title_sort selective participation of c-jun with fra-2/c-fos promotes aggressive tumor phenotypes and poor prognosis in tongue cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652185/
https://www.ncbi.nlm.nih.gov/pubmed/26581505
http://dx.doi.org/10.1038/srep16811
work_keys_str_mv AT guptashilpi selectiveparticipationofcjunwithfra2cfospromotesaggressivetumorphenotypesandpoorprognosisintonguecancer
AT kumarprabhat selectiveparticipationofcjunwithfra2cfospromotesaggressivetumorphenotypesandpoorprognosisintonguecancer
AT kaurharsimrut selectiveparticipationofcjunwithfra2cfospromotesaggressivetumorphenotypesandpoorprognosisintonguecancer
AT sharmanishi selectiveparticipationofcjunwithfra2cfospromotesaggressivetumorphenotypesandpoorprognosisintonguecancer
AT salujadaman selectiveparticipationofcjunwithfra2cfospromotesaggressivetumorphenotypesandpoorprognosisintonguecancer
AT bhartialokc selectiveparticipationofcjunwithfra2cfospromotesaggressivetumorphenotypesandpoorprognosisintonguecancer
AT dasbhudevc selectiveparticipationofcjunwithfra2cfospromotesaggressivetumorphenotypesandpoorprognosisintonguecancer